Hypokalemic periodic paralysis with unusual responses to acetazolamide and sympathomimetics.
Five members in three generations of a family were affected by an illness that had many clinical features of the hypokalemic form of periodic paralysis (HPP). The serum potassium was either moderately reduced or normal during attacks, and there was no evidence of myotonia or cold-intolerance. All of the patients improved to a variable degree with oral potassium supplements, and 3 responded favorably to triamterene. The usually beneficial drug acetazolamide, however, invariably caused weakness in these patients, an effect previously described in only one other family with HPP. In addition, amphetamine-like sympathomimetic drugs effectively aborted or prevented paralysis in several members. Muscle biopsy in two patients revealed some unusual features, and electromyography showed myopathic potentials. There was no evidence of diabetes. The urine electrolyte concentrations during glucose tolerance tests, however, were different from those previously reported in HPP. This family may represent a variant form of HPP.
Vern
B A
BA
Department of Neurology, College of Medicine, University of Illinois, Chicago 60612.
Danon
M J
MJ
Hanlon
K
K
D000086:Acetazolamide / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000201:enzymology / Q000473:pathology; D010243:Paralysis / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics; D010375:Pedigree; D013566:Sympathomimetics / Q000627:therapeutic use*
D013566:Sympathomimetics; D000086:Acetazolamide